Showing results (371-380 of 7,831) with videos related to
Sort By:
Pageof 784
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Tricyclic response in obsessive compulsive disorderT R Insel, E A Mueller, J C Gillin, et al.Psychiatry Research|May 1, 1983
Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responsesL J Siever, M S Kafka, T R Insel, et al.Psychopharmacology|January 1, 1995
Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptorsP Mazzola-Pomietto, C S Aulakh, K M Wozniak, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Anti-beta-endorphin immunoglobulin G in humansB F Roy, J W Rose, H F McFarland, et al.Archives of General Psychiatry|January 1, 1989
Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of actionC Benkelfat, D L Murphy, J Zohar, et al.Science (New York, N.Y.)|September 26, 1980
Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisolS C Risch, R M Cohen, D S Janowsky, et al.Psychopharmacology|January 1, 1982
REM sleep suppression induced by selective monoamine oxidase inhibitorsR M Cohen, D Pickar, D Garnett, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1981
Diurnal variation in cerebrospinal fluid prolactin concentration of the rhesus monkeyN H Kalin, T R Insel, R M Cohen, et al.The American Journal of Psychiatry|January 1, 1978
Platelet monoamine oxidase in chronic schizophrenic patientsP A Berger, R A Ginsburg, J D Barchas, et al.Science (New York, N.Y.)|March 2, 1973
Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophreniaR J Wyatt, D L Murphy, R Belmaker, et al.Pageof 784